SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 Denali Therapeutics Inc. , a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier .
Denali Therapeutics shares were up nearly 25% in recent Tuesday trading after the company announced a $500 million private placement equity financing and plans to spin out its preclinical small.
Complete enrollment in Denali-led, late-stage programs for MPS II and ALS, and establish commercial readinessAdvance broad clinical-stage portfolio of seven therapeutic product candidates across.
Denali Therapeutics Announces Key Anticipated 2024 Milestones And Priorities To Further Advance Its Therapeutics Portfolio For Neurodegeneration And L... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.